• 1
    Eldridge RR, Tennis P. Monitoring birth outcomes in the lamotrigine pregnancy registry [Abstract]. Epilepsia 1995;36(suppl 4):90.
  • 2
    Garnett WR. Lamotrigine: pharmacokinetics. J Child Neurol 1997;12(suppl 1):S105.
  • 3
    Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38:103941.
  • 4
    Rambeck B, Kurleman G, Stodieck SRG, May TW, Jurgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51:4814.
  • 5
    Forsblad E, Eriksson A-S, Beck O. Liquid chromatographic determination of plasma lamotrigine in pediatric samples. J Pharm Biomed Anal 1996;14:7558.
  • 6
    Miners JO, Mackenzie PI. Drug glucuronidation in humans. Pharmacol Ther 1991;51:34769.
  • 7
    Besunder JB, Reed MD, Blumer JL. Principles of drug disposition in the neonate: a critical evaluation of the pharmacokinetic/pharmacodynamic interface (part I). Clin Pharmacokinet 1988;14:189216.
  • 8
    Stewart CF, Hampton EM. Effect of maturation on drug disposition in pediatric patients. Clin Pharm 1987;6:54864.
  • 9
    Miners JO, Robson RA, Birkett DJ. Paracetamol metabolism in pregnancy. Br J Clin Pharmacol 1986;22:35962.
  • 10
    Tomson G, Lunell NO, Sundwall A, Rane A. Placental passage of oxazepam and its metabolism in mother and newborn. Clin Pharmacol Ther 1979;25:748.
  • 11
    Binnie CD, Van Emde Boas W, Kasteleij-Noite-Trenite DGA, De Korte RA, Meijer JWA. Acute effects of lamotrigine (BW4305) in persons with epilepsy. Epilepsia 1986;27:24854.
  • 12
    Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR. Lamotrigine: single dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res 1987;1:194201.
  • 13
    Nau H, Kuhnz W, Egger HJ, Rating D, Helge H. Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet 1982;7:50843.
  • 14
    Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC. Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 1998;46:54751.